01Sophia Genetics reported Q3 earnings per share of negative $0.24, missing the consensus estimate of negative $0.19 by $0.05 per share on November 3, 2026.
02Revenue reached $24.3M, exceeding the estimate of $24.0M, but the earnings miss represents a 26% negative surprise relative to consensus.
03The stock trades at $6.26 with a market capitalization of $321.5M following the earnings release.
04Sophia Genetics has missed earnings estimates for four consecutive quarters, with negative surprises ranging from 12.5% to 40.0%.
Earnings Results
Sophia Genetics (NASDAQ:SOPH) reported quarterly earnings results on November 03, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.24, missing the consensus estimate of $-0.19 by $0.05 per share. Revenue came in at $24.3M, beating the estimate of $24.0M.
Company Overview
Sophia Genetics's stock moved following the earnings release. The stock currently trades at $6.26 with a market capitalization of $321.5M.
Missing analyst estimates puts pressure on a stock as investors reassess their growth assumptions. The market's reaction to an earnings miss depends heavily on the magnitude of the shortfall, the company's forward guidance, and whether the miss was driven by temporary or structural factors.
The 26% miss relative to consensus estimates is a notable deviation. Earnings surprises of this magnitude often trigger analyst revisions and can influence institutional positioning in the weeks following the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Sophia Genetics should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.